Sea Swimming for Treatment of Depression and Anxiety
The Effect of a Sea-safety Course on Mood, Mental Wellbeing and Inflammation
1 other identifier
interventional
61
1 country
1
Brief Summary
There is a developing evidence to suggest that open cold water swimming could have an impact on depression and anxiety:
- anecdotal reports of benefits to mental wellbeing as a result of regular open water bathing
- research suggesting exercise is as effective as medication and talking therapies in the treatment of depression
- ecotherapy (offering therapeutic intervention in nature) has a developing evidence base
- cold water may have an impact on the inflammatory system which has been linked to depression The aim of this study is to recruit 10 people with mild to moderately severe depression to a sea swimming course, alongside their standard care. The course would involve two groups of 5, participating in eight sea sessions under the guidance and supervision of swim instructors and lifeguards. The primary aim of the course is to determine the recruitment rate and compliance with the course. The secondary aims of the course are to determine the impact on mental health through questionnaires for depression (PHQ9), anxiety (GAD7), functioning in daily life (WSAS). The inflammatory marker - C- reactive protein (CRP), will also be measured to monitor the inflammatory process in relation to psychological outcomes and the timeline of the course. Participants will need to commit to two sessions a week. It is anticipated that participants will need to commit around 2 hours of their time to the study each week. It would take around ten months from recruitment to follow-up. Participants would be able to leave the study at any time. Participants would engage in routine care alongside the course. Sea swimming can be a dangerous activity but participants would be well supported, in small groups and would only sea swim in safe conditions. Participants will be asked to report any medical conditions to ensure they could not be adversely effected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2020
CompletedFirst Submitted
Initial submission to the registry
August 24, 2020
CompletedFirst Posted
Study publicly available on registry
August 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 16, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 16, 2021
CompletedAugust 18, 2021
August 1, 2021
9 months
August 24, 2020
August 17, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Recruitment and retention of participants
The number of participants recruited and how many of them complete the course
5 weeks
Secondary Outcomes (4)
Effect of course on measures of anxiety
5 weeks
Effect of course on measures of depression
5 weeks
Effect of course on measures of functioning
5 weeks
Effect of course on inflammation
5 weeks
Study Arms (1)
Sea swimming
EXPERIMENTAL8 sessions over 4 weeks of swimming-based activities in the sea
Interventions
Eligibility Criteria
You may qualify if:
- Adults living in North Devon and able to attend the course.
- PHQ-9 score 5-19
- Able to swim two lengths of a 25m pool
You may not qualify if:
- Physical health problems that would make cold water immersion a risk including significant heart problems, inadequately treated high blood pressure e.g. new diagnosis not on stable medication, significantly reduced mobility.
- Experience of other mental health problems at a significant level
- Not able to swim or very anxious about getting into water
- Suicide risk
- Unable to speak English (as the sea swimming course will be conducted in English)
- Unable to consent due to lack of capacity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Croyde Beach
Croyde, Devon, United Kingdom
Related Publications (22)
Beilin B, Shavit Y, Razumovsky J, Wolloch Y, Zeidel A, Bessler H. Effects of mild perioperative hypothermia on cellular immune responses. Anesthesiology. 1998 Nov;89(5):1133-40. doi: 10.1097/00000542-199811000-00013.
PMID: 9822001BACKGROUNDBryleva EY, Keaton SA, Grit J, Madaj Z, Sauro-Nagendra A, Smart L, Halstead S, Achtyes E, Brundin L. The acute-phase mediator serum amyloid A is associated with symptoms of depression and fatigue. Acta Psychiatr Scand. 2017 May;135(5):409-418. doi: 10.1111/acps.12730. Epub 2017 Apr 4.
PMID: 28374419BACKGROUNDCanli T. Reconceptualizing major depressive disorder as an infectious disease. Biol Mood Anxiety Disord. 2014 Oct 21;4:10. doi: 10.1186/2045-5380-4-10. eCollection 2014.
PMID: 25364500BACKGROUNDCooney GM, Dwan K, Greig CA, Lawlor DA, Rimer J, Waugh FR, McMurdo M, Mead GE. Exercise for depression. Cochrane Database Syst Rev. 2013 Sep 12;2013(9):CD004366. doi: 10.1002/14651858.CD004366.pub6.
PMID: 24026850BACKGROUNDDenton, H. and Aranda K. The wellbeing benefits of sea swimming. Is it time to revisit the sea cure? Qualitative Research in Sport, Exercise and Health. 2019. pp. 1-17.
BACKGROUNDDugdill L, Graham RC, McNair F. Exercise referral: the public health panacea for physical activity promotion? A critical perspective of exercise referral schemes; their development and evaluation. Ergonomics. 2005 Sep 15-Nov 15;48(11-14):1390-410. doi: 10.1080/00140130500101544.
PMID: 16338708BACKGROUNDFoley R. Swimming in Ireland: Immersions in therapeutic blue space. Health Place. 2015 Sep;35:218-25. doi: 10.1016/j.healthplace.2014.09.015.
PMID: 25456012BACKGROUNDGabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999 Feb 11;340(6):448-54. doi: 10.1056/NEJM199902113400607. No abstract available.
PMID: 9971870BACKGROUNDHage FG, Szalai AJ. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol. 2007 Sep 18;50(12):1115-22. doi: 10.1016/j.jacc.2007.06.012. Epub 2007 Sep 4.
PMID: 17868801BACKGROUNDHolt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: a meta-analytic review. PLoS Med. 2010 Jul 27;7(7):e1000316. doi: 10.1371/journal.pmed.1000316.
PMID: 20668659BACKGROUNDIacobucci G. NHS prescribed record number of antidepressants last year. BMJ. 2019 Mar 29;364:l1508. doi: 10.1136/bmj.l1508. No abstract available.
PMID: 30926584BACKGROUNDJones A, Hillsdon M, Coombes E. Greenspace access, use, and physical activity: understanding the effects of area deprivation. Prev Med. 2009 Dec;49(6):500-5. doi: 10.1016/j.ypmed.2009.10.012. Epub 2009 Oct 24.
PMID: 19857513BACKGROUNDMaes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharpe S. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res. 1997 Jan 15;66(1):1-11. doi: 10.1016/s0165-1781(96)02915-0.
PMID: 9061799BACKGROUNDMarkanday A. Acute Phase Reactants in Infections: Evidence-Based Review and a Guide for Clinicians. Open Forum Infect Dis. 2015 Jul 3;2(3):ofv098. doi: 10.1093/ofid/ofv098. eCollection 2015 Sep.
PMID: 26258155BACKGROUNDMuller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, Moller HJ, Arolt V, Riedel M. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry. 2006 Jul;11(7):680-4. doi: 10.1038/sj.mp.4001805. Epub 2006 Feb 21.
PMID: 16491133BACKGROUNDMurray, C. J. L. et al. (1996) 'The Global burden of disease : a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 : summary / edited by Christopher J. L. Murray, Alan D. Lopez'. Geneva PP - Geneva: World Health Organization (Global burden of disease and injury series, volume 1). Available at: https://apps.who.int/iris/handle/10665/41864.
BACKGROUNDPepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003 Jun;111(12):1805-12. doi: 10.1172/JCI18921. No abstract available.
PMID: 12813013BACKGROUNDPizzo PA. A Prescription for Longevity in the 21st Century: Renewing Purpose, Building and Sustaining Social Engagement, and Embracing a Positive Lifestyle. JAMA. 2020 Feb 4;323(5):415-416. doi: 10.1001/jama.2019.21087. No abstract available.
PMID: 31917444BACKGROUNDRidker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003 Jan 28;107(3):363-9. doi: 10.1161/01.cir.0000053730.47739.3c. No abstract available.
PMID: 12551853BACKGROUNDTangvarasittichai S, Pongthaisong S, Tangvarasittichai O. Tumor Necrosis Factor-Alpha, Interleukin-6, C-Reactive Protein Levels and Insulin Resistance Associated with Type 2 Diabetes in Abdominal Obesity Women. Indian J Clin Biochem. 2016 Mar;31(1):68-74. doi: 10.1007/s12291-015-0514-0. Epub 2015 Jul 26.
PMID: 26855490BACKGROUNDTipton MJ, Collier N, Massey H, Corbett J, Harper M. Cold water immersion: kill or cure? Exp Physiol. 2017 Nov 1;102(11):1335-1355. doi: 10.1113/EP086283. Epub 2017 Sep 21.
PMID: 28833689BACKGROUNDvan Tulleken C, Tipton M, Massey H, Harper CM. Open water swimming as a treatment for major depressive disorder. BMJ Case Rep. 2018 Aug 21;2018:bcr2018225007. doi: 10.1136/bcr-2018-225007.
PMID: 30131418BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
C Mark Harper, MBBS
Brighton and Sussex University Hospitals
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2020
First Posted
August 27, 2020
Study Start
July 1, 2020
Primary Completion
March 16, 2021
Study Completion
March 16, 2021
Last Updated
August 18, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share